Bayer Says It’s Now Targeted in 18,400 Glyphosate Cases in the U.S.
German pharmaceutical giant Bayer said on Tuesday, July 30, it is now targeted in some 18,400 US legal cases over glyphosate, a key herbicide ingredient that plaintiffs say caused grave illnesses like cancer. "As of July 11, 2019, lawsuits from approximately 18,400 plaintiffs had been served in the United States in connection with the crop protection product glyphosate."
July 30, 2019 | Source: Rappler | by Agence France-Presse
The wave of lawsuits follows its takeover of US seeds and pesticides maker Monsanto last year for $63 billion, one of the largest foreign mergers ever by a German company
German pharmaceutical giant Bayer said on Tuesday, July 30, it is now targeted in some 18,400 US legal cases over glyphosate, a key herbicide ingredient that plaintiffs say caused grave illnesses like cancer.
“As of July 11, 2019, lawsuits from approximately 18,400 plaintiffs had been served in the United States in connection with the crop protection product glyphosate,” Bayer said in a statement.
In April, the number of cases stood at 13,400.
The wave of lawsuits has crashed onto Bayer since its takeover of US seeds and pesticides maker Monsanto last year for $63 billion, one of the largest foreign mergers ever by a German company.
In the first few cases to be heard, juries in lower courts have found in favour of plaintiffs, agreeing that blood cancer non-Hodgkins lymphoma had been caused by glyphosate-containing products, including Monsanto’s flagship Roundup weedkiller.